Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potential biologic therapies for the intervertebral disc.

Christopher Evans1

  • 1Center for Molecular Orthopaedics, Harvard Medical School, 221 Longwood Avenue, BLI-152, Boston, MA 02115, USA. cevans@rics.bwh.harvard.edu

The Journal of Bone and Joint Surgery. American Volume
|April 6, 2006
PubMed
Summary

Gene therapy offers a promising approach for disc degeneration by delivering therapeutic proteins. This method ensures sustained protein presence, addressing the limitations of traditional protein injections for chronic conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mineral Stabilization Slows Losses of Peatland Carbon Following Long-Term Drainage for Agriculture.

Global change biology·2026
Same author

The impact of neighbourhood-level marginalization on risk of opioid overdose: a population-based retrospective cohort study.

The International journal on drug policy·2026
Same author

Guidance for the Knowledge and Skills required for Antimicrobial Stewardship Leaders: an update from the Society for Healthcare Epidemiology of America, Infectious Diseases Society of America, Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2026
Same author

A therapeutic-grade purified exosome system alleviates osteoarthritis by regulating autophagy through the BCL2-Beclin1 axis.

Journal of nanobiotechnology·2025
Same author

Development of patient-centric conceptual frameworks for symptoms and impacts of ornithine transcarbamylase deficiency (OTCD).

Journal of patient-reported outcomes·2025
Same author

Fracture nonunions.

OTA international : the open access journal of orthopaedic trauma·2025

Area of Science:

  • Biomolecular Engineering
  • Regenerative Medicine
  • Cell Biology

Background:

  • Intervertebral disc degeneration is a chronic condition requiring long-term therapeutic protein presence.
  • Intradiscal protein injections have limited efficacy due to short-term presence.
  • Declining cellularity in degenerating discs necessitates strategies to restore cell numbers.

Purpose of the Study:

  • To explore gene therapy as a superior delivery system for therapeutic proteins in disc degeneration.
  • To investigate methods for restoring cellularity in degenerating discs, including progenitor cell transplantation.
  • To highlight the need for identifying disc cell markers for effective cell therapy.

Main Methods:

  • Review of biological strategies for disc restoration, including protein and gene therapy.

Related Experiment Videos

  • Discussion of recombinant bone morphogenetic protein-7 (osteogenic protein-1) and cytokine antagonists.
  • Exploration of in situ genetic modification and progenitor cell transplantation.

    • Main Results:

    • Gene therapy may provide a more effective delivery system for sustained therapeutic protein levels.
    • Restoring disc cell numbers, potentially through progenitor cells, is crucial for successful treatment.
    • The lack of specific disc cell markers impedes the confirmation of progenitor cell differentiation.

    Conclusions:

    • Gene therapy holds promise for sustained delivery of therapeutic proteins to combat disc degeneration.
    • Cellular restoration strategies, particularly using progenitor cells, are vital but require further research.
    • Development of molecular markers for disc cells is essential for advancing cell-based therapies.